Pharma Manufacturing Outsourcing: 2014 in Review

Jan 03, 2015
By Pharmaceutical Executive Editors

According to BioPlan’s 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, which identifies various industry trends, almost all areas of R&D and manufacturing are at least in contention for some degree of outsourcing. 

BioPlan’s study noted for 2014 a year-over-year increase in the use of many of the most popular outsourcing activities, such as toxicity testing, fill/finish operations and validation services.

There was a general pullback, however, in the less commonly outsourced activities. This article by Pharmaceutical Technology's Eric Langer looks closely at the findings. 

native1_300x100
lorem ipsum